Bonjour ,
Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.
% complété
%
2 Ce profil est validé par 2 label.
Company
LS CancerDiag
45
EQ SCORE L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.
LS CancerDiag has developed DiagMMR®, a unique predictive diagnostic test to detect Lynch syndrome (LS). We provide easily interpretable and highly accurate results even before cancers develop, enabling preventive and personalized care.
Helsinki, Uusimaa, Finland
Send a message
- 9
employees
- €10,000
turnover
Anglais
LS CancerDiag
Anglais
LS CancerDiag is committed to reducing cancer mortality rates with a diagnostic method that detects an inherited cancer-causing condition prior to cancer.
DiagMMR® is designed to be a predictive diagnostic tool that enables preventive follow-up and counselling for affected mutation carriers who are at high risk for developing Lynch syndrome related cancers. While current LS diagnosis relies on tumor studies, the quantitative DiagMMR® method allows carrier diagnosis based on a...
LS CancerDiag is committed to reducing cancer mortality rates with a diagnostic method that detects an inherited cancer-causing condition prior to cancer.
DiagMMR® is designed to be a predictive diagnostic tool that enables preventive follow-up and counselling for affected mutation carriers who are at high risk for developing Lynch syndrome related cancers. While current LS diagnosis relies on tumor studies, the quantitative DiagMMR® method allows carrier diagnosis based on a non-invasive tissue sample before the person has developed a cancer, without the knowledge and details of an inherited mutation.
-
2
Followers
-
1
Like
Team member(s)
Your request has been sent
Join this organization
Your request has been sent
Our network
Your request has been sent
Join this network
Your message has been sent
Certifications
The Seal of Excellence is a quality label awarded to project proposals submitted to Horizon 2020 which succeeded a highly competitive evaluation process by independent experts, but did not received funding due to budget limits.
This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential.
1470 Entities
The InvestHorizon Accelerated label is for selected deep tech companies from the accelerator programme to facilitate series A funding.
This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential.
InvestHorizon is a programme financed by the European Commission in association with Eureka to foster investment readiness.
332 Entities
Communities
The Access2EIC -Seal of Excellence community aims at gathering high potential European companies that received from the European Commission a “Seal of Excellence” certificate and European equity investors.
https://access2eic.eu/
2111 Members
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding
for selected DEEP TECH companies.
1629 Members
Our history
Start in Aug 2013
-
Aug 2013
LS CancerDiag is founded as a Spin-off from the University of Helsinki.
-
2014-2018
Patents filed and granted in all major markets (incl. EU, USA, China, Russia, Japan)
-
2016
LS CancerDiag joins Startup Health.
-
2018
Optimization and validation is completed.
-
2019
CE-mark obtained as IVD MD. Distribution agreements signed in Finland.
to be continued ...